Literature DB >> 6981471

Defective B cell function in systemic lupus erythematosus.

B K Pelton, A M Denman.   

Abstract

The in vitro synthesis of specific anti-influenza virus antibody was measured in cultures of peripheral blood lymphocytes from 25 patients with systemic lupus erythematosus (SLE) and 23 control subjects. Whilst all cultures derived from normal individuals synthesized specific antibody, cultures from patients with SLE were consistently unable to produce anti-influenza antibody. This defect could not be corrected by manipulating the culture conditions or by in vivo immunization. Co-cultivation of separated SLE-B or control B cells, with SLE-T or control T cells showed that the immunodeficiency exhibited by the SLE peripheral blood lymphocytes resides in the B cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6981471      PMCID: PMC1536611     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Characterization of mononuclear effector cells in human blood.

Authors:  P Hersey; A Edwards; J Edwards
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

2.  Susceptibility of human lymphocyte populations to infection by herpes simplex virus.

Authors:  B K Pelton; R C Imrie; A M Denman
Journal:  Immunology       Date:  1977-05       Impact factor: 7.397

3.  Depressed in vitro B-lymphocyte differentiation in systemic lupus erythematosus.

Authors:  A M Bobrove; P Miller
Journal:  Arthritis Rheum       Date:  1977 Sep-Oct

Review 4.  Disordered immunologic regulation and autoimmunity.

Authors:  N Talal
Journal:  Transplant Rev       Date:  1976

5.  Specific in vitro antibody response to varicella zoster.

Authors:  R L Souhami; J Babbage; R E Callard
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

6.  Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE.

Authors:  D R Budman; E B Merchant; A D Steinberg; B Doft; M E Gershwin; E Lizzio; J P Reeves
Journal:  Arthritis Rheum       Date:  1977-04

7.  Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.

Authors:  R P Messner; F D Lindström; R C Williams
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

8.  Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus.

Authors:  B Bresnihan; H E Jasin
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

9.  Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus.

Authors:  J Baum; M Ziff
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

10.  In vitro TNP-specific antibody formation by peripheral lymphocytes from patients with systemic lupus erythematosus.

Authors:  C Morimoto; T Abe; M Hara; M Homma
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

View more
  12 in total

1.  Heptavax-B in pediatric dialysis patients: effect of systemic lupus erythematosus. Chesapeake Pediatric Nephrology Study Group.

Authors:  M M Moxey-Mims; K Preston; B Fivush; F McCurdy
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

Review 2.  Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  L Turner-Stokes; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

3.  The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus.

Authors:  P S Mach; M Kharouby; F Lutcher; J L Olivier; N Bazely; M Dougados; B Amor
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

4.  Specific allogeneic help by T lymphocytes from patients with systemic lupus erythematosus.

Authors:  M K Hari Kumar; R A Knight; M L Snaith
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

5.  B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis.

Authors:  C G Kallenberg; P C Limburg; C Van Slochteren; F J Van der Woude; T H The
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

6.  Antigen-specific B-cell function in human autoimmune thyroiditis.

Authors:  E De Bernardo; T F Davies
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

7.  Immunoregulatory effects of interferon-alpha. I. Interferon-alpha inhibits in vitro antibody synthesis by normal human lymphocytes.

Authors:  B K Pelton; A M Denman
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

8.  Immunoregulatory effects of alpha-interferon. Effects on in-vitro antibody synthesis by lymphocytes from patients with rheumatoid arthritis.

Authors:  B K Pelton; A M Denman
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

9.  The rheumatoid synovial membrane participates in systemic anti-viral immune responses.

Authors:  B K Pelton; A R Harvey; A M Denman
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

10.  Spontaneous production of B cell growth factors by SLE lymphocytes.

Authors:  B K Pelton; A M Denman
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.